Search

The aqueous solution cast method was used to create the biodegradable polymer nanocomposite (PNC) films from a blend of poly (vinyl alcohol) PVA and poly (vinyl pyrrolidone) PVP (70/30 wt %) and Fe2O3 nanoparticles (NPs). These PNC films were characterized using X-ray diffraction, scanning electron microscopy SEM, Fourier transform infrared spectroscopy FTIR, and ultraviolet-visible spectroscopy. XRD and FTIR results indicate that Fe+ 3 NPs interact with the host polymer. Optical, electrical, mechanical, and radiation shielding measurements were performed on the PNC films. From the optical measurements, the indirect optical band gap drops from 4.86 eV for the pure blend to 4.26 eV at the greatest NPs concentration. Optical limiting characterization shows that the output power of He-Ne and solid-state green laser beams is reduced from 22.98 to 3.6 mW and 6.59 to 1.4 mW, respectively, when the Fe2O3 NPs content in the blend matrix is increased to 6 wt %. The NGCal software was utilized to calculate nuclear radiation shielding properties. The findings demonstrated that when the concentration of Fe2O3 rose, the PNC films half-value layer and mean free path decreased. Mechanical measurements demonstrate that increasing the Fe2O3 content significantly improves nanocomposite films' yield and tensile strength. Tensile strength is measured at 27.03 MPa for the composite film containing 6 wt % Fe2O3, which is significantly higher than the 8.66 MPa of the pure (PVA-PVP) film. Compared to the other samples under examination, the 6 wt % Fe2O3 sample yielded the best results (based on the analyzed optical, electrical, mechanical, and radiation shielding properties). [ABSTRACT FROM AUTHOR]

The hunt for sustainable and efficient energy harvesting and storage devices has driven significant interest in triboelectric nanogenerators (TENGs) as potential alternatives to traditional batteries for powering electronic devices. However, the development of biodegradable TENGs remains a formidable challenge. This study presents the preparation of a tribopositive material entirely composed of biodegradable poly(butylene adipate-co-terephthalate) (PBAT) polymer enhanced with CoFe2O4 (CF) nanoparticles. The CF nanoparticles, synthesized via the combustion method, were incorporated into the PBAT matrix through solvent casting to form films with varied filler content (0.2, 0.4, 0.6, 0.8, and 1 g). The CF nanoparticles structural, surface, and electrical properties were characterized using XRD and FTIR spectroscopy. At the same time, the morphology of the nanomaterials and their composites was analyzed by scanning electron microscopy. Specifically, the 0.8 g PBAT-CF TENG demonstrated superior performance, achieving an output voltage of 45.45 V and a current of 4.5 µA. Subsequent electrical studies, including charging commercial capacitors (1.0 to 47 μF) and powering LEDs and calculators, underscored the device's efficiency. The PBAT-CF TENG also effectively generated voltage and current signals from physical activities like walking and jumping. This innovative approach highlights the potential for biodegradable, high-performing, self-powered flexible electronics, and wearable devices, paving the way for sustainable technological advancements. [ABSTRACT FROM AUTHOR]

[Display omitted] Monodisperse nanoparticles of biodegradable polyhydroxyalkanoates (PHAs) polymers, copolymers of 3-hydroxybutyrate (3HB) and 4-hydroxybutyrate (4HB), are synthesized using a membrane-assisted emulsion encapsulation and evaporation process for biomedical resorbable adhesives. The precise control over the diameter of these PHA particles, ranging from 100 nm to 8 μm, is achieved by adjusting the diameter of emulsion or the PHA concentration. Mechanical properties of the particles can be tailored based on the 3HB to 4HB ratio and molecular weight, primarily influenced by the level of crystallinity. These monodisperse PHA particles in solution serve as adhesives for hydrogel systems, specifically those based on poly(N , N -dimethylacrylamide) (PDMA). Semi-crystalline PHA nanoparticles exhibit stronger adhesion energy than their amorphous counterparts. Due to their self-adhesiveness, adhesion energy increases even when those PHA nanoparticles form multilayers between hydrogels. Furthermore, as they degrade and are resorbed into the body, the PHA nanoparticles demonstrate efficacy in in vivo wound closure, underscoring their considerable impact on biomedical applications. [ABSTRACT FROM AUTHOR]

Chemotherapy for hepatoblastoma is limited by organ toxicity and poor outcomes, prompting the search for new, more effective treatments with minimal side effects. Vincristine sulfate, a potent chemotherapeutic, faces challenges due to P-glycoprotein-mediated resistance and its systemic toxicity. Nanoparticles offer a promising solution by improving pharmacokinetics, targeting tumor cells, thus reducing side effects. Moreover, the use of fluorescent nanomaterials is emerging in biomedical applications such as bioimaging, detection and therapies. This study describes a promising delivery system utilizing carbon dots encapsulated with vincristine in biodegradable polycaprolactone nanoparticles via a double emulsion technique. The fine characterization of these nanoparticles showed that they are spherical, uniformly sized with around 200 nm and exhibit excellent colloidal stability. Moreover, the release profile showed prolonged release for both vincristine and carbon dots. In vitro cell viability studies revealed enhanced cancer cell inhibition for the encapsulated drug compared to the vincristine solution. The uptake study indicated clear fluorescence for carbon dots solution and vincristine and carbon dots loaded nanoparticles upon excitation. Additionally, studies on primary mouse hepatocytes demonstrated higher fluorescence intensity in treatment groups. These results suggest that vincristine and carbon dots loaded nanoparticles are effective, target-specific carriers for liver cancer treatment. Furthermore, the carbon dots were not cytotoxic, highlighting their potential in bioimaging and cancer cell studies. [ABSTRACT FROM AUTHOR]

4D printing magneto‐responsive shape memory polymers (SMPs) using biodegradable nanocomposites can overcome their low toughness and thermal resistance, and produce smart materials that can be controlled remotely without contact. This study presented the development of 3D/4D printable nanocomposites based on poly (lactic acid) (PLA)‐poly (butylene adipate‐co‐terephthalate) (PBAT) blends and magnetite (Fe3O4) nanoparticles. The nanocomposites are prepared by melt mixing PLA‐PBAT blends with different Fe3O4 contents (10, 15, and 20 wt%) and extruded into granules for material extrusion 3D printing. The morphology, dynamic mechanical thermal analysis (DMTA), mechanical properties, and shape memory behavior of the nanocomposites are investigated. The results indicated that the Fe3O4 nanoparticles are preferentially distributed in the PBAT phases, enhancing the storage modulus, thermal stability, strength, elongation, toughness, shape fixity, and recovery of the nanocomposites. The optimal Fe3O4 loading is found to be 10 wt%, as higher loadings led to nanoparticle agglomeration and reduced performance. The nanocomposites also exhibited fast shape memory response under thermal and magnetic activation due to the presence of Fe3O4 nanoparticles. The 3D/4D printable nanocomposites demonstrated multifunctional multi‐trigger shape‐memory capabilities and potential applications in contactless and safe actuation. [ABSTRACT FROM AUTHOR]

Hybrid nanocomposites combining biopolymer fibers incorporated with nanoparticles (NPs) have received increasing attention due to their remarkable characteristics. Inorganic NPs are typically chosen for their properties, such as magnetism and thermal or electrical conductivity, for example. Meanwhile, the biopolymer fiber component is a backbone, and could act as a support structure for the NPs. This shift towards biopolymers over traditional synthetic polymers is motivated by their sustainability, compatibility with biological systems, non-toxic nature, and natural decomposition. This study employed the solution blow spinning (SBS) method to obtain a nanocomposite comprising poly(vinyl pyrrolidone), PVA, and gelatin biodegradable polymer fibers incorporated with magnetic iron oxide nanoparticles coated with poly(acrylic acid), PAA2k, coded as γ-Fe2O3-NPs-PAA2k. The fiber production process entailed a preliminary investigation to determine suitable solvents, polymer concentrations, and spinning parameters. γ-Fe2O3-NPs were synthesized via chemical co-precipitation as maghemite and coated with PAA2k through the precipitation–redispersion protocol in order to prepare γ-Fe2O3-NPs-PAA2k. Biopolymeric fibers containing coated NPs with sub-micrometer diameters were obtained, with NP concentrations ranging from 1.0 to 1.7% wt. The synthesized NPs underwent characterization via dynamic light scattering, zeta potential analysis, and infrared spectroscopy, while the biopolymer fibers were characterized through scanning electron microscopy, infrared spectroscopy, and thermogravimetric analysis. Overall, this study demonstrates the successful implementation of SBS for producing biopolymeric fibers incorporating iron oxide NPs, where the amalgamation of materials demonstrated superior thermal behavior to the plain polymers. The thorough characterization of the NPs and fibers provided valuable insights into their properties, paving the way for their potential applications in various fields such as biomedical engineering, environmental remediation, and functional materials. [ABSTRACT FROM AUTHOR]

Magnetic nanomaterials have emerged as an effective drug‐delivery platform for targeted imaging and therapy. However, it remains challenging to fabricate biodegradable magnetic nanoparticles with controllable drug release behaviors and strong magnetic responsiveness. Here an asiaticoside‐loaded biodegradable magnetic vesicle is developed based on the self‐assembly of amphiphilic block copolymer tethered superparamagnetic iron oxide nanoparticles. Thanks to the collective properties, the magnetic vesicles show stronger magnetic responsiveness than individual nanoparticles. Additionally, the magnetic vesicles are dissociated within weeks owing to the biodegradable polymer backbone, which can significantly improve the long‐term biocompatibility of the nanomaterials. The asiaticoside‐loaded magnetic vesicles can readily release the payloads in an alternating magnetic field, likely due to the rising local temperature over the phase transition temperature of the polymers attached on nanoparticles. This work provides new insights into the design and construction of biodegradable magnetic nanomedicines for targeted drug delivery. [ABSTRACT FROM AUTHOR]

AbstractNaringenin may play a role in browning by increasing thermogenic gene expression. In this study, we encapsulated naringenin using a liposomal formulation and examined the effects of both free and liposomal naringenin on white adipose tissue browning in C57BL6/J mice. In the first phase of the study, naringenin was encapsulated by the liposome method, which is biocompatible and biodegradable. The physical and chemical properties of liposomal naringenin were tested. In the second phase, a total of 48 six-week-old mice were divided into two main groups: prevention and recovery. Each main group was divided into four subgroups: nano-naringenin, void, free-naringenin, and control. The prevention group received a high-fat diet for 10 weeks along with weekly intravenous injections of 20 µM naringenin. On the other hand, the recovery group was first subjected to a high-fat diet for 10 weeks, followed by an additional 10 weeks of the same diet, along with weekly intravenous injections of 20 µM naringenin. Body weight was measured once per week, and brown adipose tissue, inguinal white adipose tissue, and serum samples were collected from each mouse. The mean particle size, polydispersity index and zeta potential values of liposomal naringenin were ∼207 nm, 0.35, and −27 mV, respectively. The encapsulation and loading efficiencies of liposomal naringenin were 94.6 and 19.2%, respectively. Liposomal naringenin exhibited sustained-release behavior, while free naringenin showed a burst-release profile. Liposomal naringenin showed the best physical stability in light and at 4 °C, while free naringenin was more chemically stable in light and at 4 and 22 °C. Free and liposomal naringenin did not significantly reduce weight gain. In the prevention group, liposomal naringenin increased PRDM16 gene expression in inguinal white adipose tissue 4.29 times more than free naringenin (p = 0.010). However, neither formulation significantly altered the expression levels of other browning or adipogenesis markers in the tissues. The results suggest that free naringenin can be efficiently encapsulated in biocompatible and biodegradable nanoparticles. Further research is needed to better understand the physiological effects of liposomal naringenin. [ABSTRACT FROM AUTHOR]

The development of triboelectric nanogenerators (TENGs) using sustainable materials addresses the global electronic waste issue. This research focuses on fabricating a TENG device with biodegradable polylactic acid (PLA) as the tribopositive material and polytetrafluoroethylene (PTFE) as the tribonegative material. ZnFe2O4 nanoparticles are incorporated into the PLA matrix to enhance surface charge density and synthesised via a simple combustion method. PLA-ZnFe2O4 composite films were prepared by solvent casting with varying nanofiller content (0.25, 0.45, 0.65, and 0.85 g). Prepared composites were characterised by Powder X-ray Diffraction (PXRD) for crystalline nature and phase purity, Fourier Transform Infrared Spectroscopy (FTIR) for vibrational analysis, and Scanning Electron Microscopy (SEM) for surface morphology. The inclusion of ZnFe2O4 nanoparticles improves TENG output performance, with a maximum output voltage of 18.4 V and a current of 1.57 µA observed for a PLA (poly(lactic acid)) composite with 39.39% nanoparticle content. Electrical studies on the optimised device show successful charging of various capacitors and powering 20 LEDs and a calculator. Body movements like walking and jumping were also tested to measure voltage and current outputs. These findings highlight new possibilities for developing smart, self-powered electronic devices. [ABSTRACT FROM AUTHOR]

In the last few decades, there has been a growing interest in the use of biodegradable polymeric nanoparticles (BPNPs) as the carriers for various therapeutic agents in drug delivery systems. BPNPs have the potential to improve the efficacy of numerous active agents by facilitating targeted delivery to a desired site in the body. Biodegradable polymers are especially promising nanocarriers for therapeutic substances characterized by poor solubility, instability, rapid metabolism, and rapid system elimination. Such molecules can be efficiently encapsulated and subsequently released from nanoparticles, which greatly improves their stability and bioavailability. Biopolymers seem to be the most suitable candidates to be used as the nanocarriers in various delivery platforms, especially due to their biocompatibility and biodegradability. Other unique properties of the polymeric nanocarriers include low cost, flexibility, stability, minimal side effects, low toxicity, good entrapment potential, and long-term and controlled drug release. An overview summarizing the research results from the last years in the field of the successful fabrication of BPNPs loaded with various therapeutic agents is provided. The possible challenges involving nanoparticle stability under physiological conditions and the possibility of scaling up production while maintaining quality, as well as the future possibilities of employing BPNPs, are also reviewed. [ABSTRACT FROM AUTHOR]

This study explores the synergistic effects of chitosan-coated cadmium sulphide (CdS) nanoparticles (NPs) at varying concentrations on their structural, optical, and photocatalytic properties. CdS NPs are known for their promising photocatalytic potential, but their practical application often requires stability enhancement and reduced toxicity. Chitosan, a natural biopolymer, offers unique advantages such as biocompatibility and heavy metal adsorption capabilities, making it an attractive candidate for surface modification of CdS NPs. Our investigation reveals that chitosan-coated CdS NPs exhibit concentration-dependent changes in their crystalline structure, bandgap energy, particle size, and vibrational characteristics. Notably, CdS NPs synthesized with 1.5 g chitosan concentration display the smallest bandgap and particle size, suggesting optimal photocatalytic activity. This research provides valuable insights into tailoring CdS NPs for efficient visible light photocatalysis, with implications in environmental remediation and energy conversion. [Display omitted] • Synergistic effects of chitosan-coated cadmium sulphide (CdS) nanoparticles (NPs). • Chitosan-coated CdSNP exhibit dose-dependent changes crystalline structure. • Bandgap energy, particle size, and vibrational characteristics were validated. • 1.5 g chitosan displayed smallest bandgap, size, at optimal photocatalytic activity. • Provides insights into tailoring CdS NPs for efficient visible light photocatalysis. [ABSTRACT FROM AUTHOR]

AbstractIn our research described in this paper, the metal-organic framework MOF-2 [Zn2(BDC)2] was used to enhance the properties of a biodegradable blend based on poly(lactic acid) (PLA) and poly(butylene adipate-co-terephthalate) (PBAT). PLA/PBAT/(1, 3, 5, and 7 wt%) MOF-2 blends were prepared using a melt blending technology with a twin-screw extruder. The phase morphology, rheological behavior and barrier properties of the blends were studied. X-ray diffraction (XRD) showed a slight increase in the crystalline content of the PLA/PBAT matrix with increasing MOF-2 content. Scanning electron microscopy (SEM) revealed that the PLA/PBAT blend was immiscible, and the phase morphology improved with MOF-2 by enhancing the interfacial compatibility, reducing the size of micro-domains and cavities, and promoting a transition to a co-continuous morphology, indicating better miscibility. The ternary nanocomposites with 5 and 7 wt% MOF-2 showed increased complex viscosity (η*) and storage modulus (G′) compared to those with 1 and 3% MOF-2, indicating stronger percolated networks. The thermal and barrier properties and water absorption capacity were also improved, confirming the rheological measurements. All the results showed that the PLA/PBAT/MOF-2 nanocomposites could be used in the field of packaging. [ABSTRACT FROM AUTHOR]

Aim: The aim of current study is the development and optimization of biodegradable polymeric nanoparticles (NPs) to be used in the field of Endodontics as intracanal medication in cases of avulsed teeth with extended extra‐oral time, utilizing PLGA polymers loaded with the anti‐inflammatory drug clobetasol propionate (CP). Methodology: CP‐loaded nanoparticles (CP‐NPs) were prepared using the solvent displacement method. CP release profile from CP‐NPs was assessed for 48 h against free CP. Using extracted human teeth, the degree of infiltration inside the dentinal tubules was studied for both CP‐NPs and CP. The anti‐inflammatory capacity of CP‐NPs was evaluated in vitro measuring their response and reaction against inflammatory cells, in particular against macrophages. The enzyme‐linked immunosorbent assay (ELISA) was used to examine the cytokine release of IL‐1β and TNF‐α. Results: Optimized CP‐NPs displayed an average size below 200 nm and a monomodal population. Additionally, spherical morphology and non‐aggregation of CP‐NPs were confirmed by transmission electron microscopy. Interaction studies showed that CP was encapsulated inside the NPs and no covalent bonds were formed. Moreover, CP‐NPs exhibited a prolonged and steady release with only 21% of the encapsulated CP released after 48 h. Using confocal laser scanning microscopy, it was observed that CP‐NPs were able to display enhanced penetration into the dentinal tubules. Neither the release of TNF‐α nor IL‐1β increased in CP‐NPs compared to the LPS control, displaying results similar and even less than the TCP after 48 h. Moreover, IL‐1β release in LPS‐stimulated cells, decreased when macrophages were treated with CP‐NPs. Conclusions: In the present work, CP‐NPs were prepared, optimized and characterized displaying significant increase in the degree of infiltration inside the dentinal tubules against CP and were able to significantly reduce TNF‐α release. Therefore, CP‐NPs constitute a promising therapy for the treatment of avulsed teeth with extended extra‐oral time. [ABSTRACT FROM AUTHOR]

Green-synthesis of biodegradable polymeric curcumin-nanoparticles using affordable biodegradable polymers to enhance curcumin's solubility and anti-oxidative potential. The curcumin-nanoparticle was prepared based on the ionic-interaction method without using any chemical surfactants, and the particle-size, zeta-potential, surface-morphology, entrapmentefficiency, and in-vitro drug release study were used to optimise the formulation. The antioxidant activity was investigated using H2DCFDA staining in the zebrafish (Danio rerio) model. The mean-diameter of blank nanoparticles was 178.2 nm (±4.69), and that of curcuminnanoparticles was about 227.7 nm (±10.4), with a PDI value of 0.312 (±0.023) and 0.360 (±0.02). The encapsulation-efficacy was found to be 34% (±1.8), with significantly reduced oxidative-stress and toxicity (∼5 times) in the zebrafish model compared to standard curcumin. The results suggested that the current way of encapsulating curcumin using affordable, biodegradable, natural polymers could be a better approach to enhancing curcumin's water solubility and bioactivity, which could further be translated into potential therapeutics. [ABSTRACT FROM AUTHOR]

AbstractA series of photoluminescent nanocomposite polyurethane adhesives were elaborated from a chemoenzymatic prepared diol of caprolactone (PCL-diol) and ethylene glycol with an excess of two different isocyanates: i) hexamethylene (HDI) and (ii) isophorone (IPDI)) diisocyanates. Adhesive formulations were filled with functionalized poly(amido-amine) (PAMAM) carbon nanotubes (f-MWNTs) and carbon quantum dots (CQDTs). Dry swine gut was used as substrate and mechanical tests were performed to explore the performance of the adhesives. The obtained materials were characterized by infrared spectroscopy (FT-IR), energy surface by contact angle, differential scanning calorimetry (DSC), hydrolytic degradation, and mechanical testing under tension, lap shear, T-peel, wound closure, and burst pressure. Among the main results were the formation of covalent bonds between the substrate and the adhesive, and the fact that the mechanical strength of the nanocomposite adhesives was superior to that of the unfilled adhesives. Compatibility of nanocomposites with the substrate was achieved by increasing wettability by the incorporation of both nanofillers. Also, adhesives filled with only CQDTs and with MWNTs-CDQTs combined showed photoluminescence activity under ultraviolet light. [ABSTRACT FROM AUTHOR]

Targeted drug delivery systems are employed to administer pharmaceutical medication, facilitating the precise delivery of drugs to specific diseased areas. Several drug delivery systems utilise carriers such as antibodies, transdermal patches, biodegradable polymers, Nanoparticles (NPs), liposomes, niosomes, and microspheres. Niosomes, on the other hand, represent a promising and innovative category of vesicular systems. Non-ionic surfactant vesicles commonly referred to as niosomes, have garnered significant attention within the pharmaceutical industry due to their remarkable capacity to versatility in encapsulation for both hydrophilic and hydrophobic drugs. Recent studies have demonstrated the potential of these vesicles to enhance the bioavailability of drugs, making them a promising strategy for delivering various therapeutic agents such as gene materials, protein therapeutics, and chemical pharmaceuticals. This approach offers minimal toxicity and desirable targeting effectiveness. Niosomes has non-immunogenic properties and can be designed as a controlled release drug that payload slowly and steadily, reducing the risk of side effects and improving therapeutic efficacy. Niosomes are substantially more stable during the preparation and storage procedure than liposomes. Liposomes are generally less stable than niosomes due to their susceptibility to enzymatic degradation and leakage of encapsulated materials. The desired pharmacokinetics property can be attained through the optimization of constituents or surface modifications. This novel method of distribution is also facile to establish and expand while maintaining cost-effective manufacturing expenses. This review article elucidates the fundamentals of niosomes as non-ionic surfactant vesicles, including their structure and components, as well as various formulation methods. Additionally, the article explores the diverse applications of niosomal in analgesics. [ABSTRACT FROM AUTHOR]

Targeted alpha therapy (TAT) relies on chemical affinity or active targeting using radioimmunoconjugates as strategies to deliver α-emitting radionuclides to cancerous tissue. These strategies can be affected by transmetalation of the parent radionuclide by competing ions in vivo and the bond-breaking recoil energy of decay daughters. The retention of α-emitting radionuclides and the dose delivered to cancer cells are influenced by these processes. Encapsulating α-emitting radionuclides within nanoparticles can help overcome many of these challenges. Poly(lactic-co-glycolic acid) (PLGA) nanoparticles are a biodegradable and biocompatible delivery platform that has been used for drug delivery. In this study, PLGA nanoparticles are utilized for encapsulation and retention of actinium-225 ([225Ac]Ac3+). Encapsulation of [225Ac]Ac3+ within PLGA nanoparticles (Zave = 155.3 nm) was achieved by adapting a double-emulsion solvent evaporation method. The encapsulation efficiency was affected by both the solvent conditions and the chelation of [225Ac]Ac3+. Chelation of [225Ac]Ac3+ to a lipophilic 2,9-bis-lactam-1,10-phenanthroline ligand ([225Ac]AcBLPhen) significantly decreased its release (< 2%) and that of its decay daughters (< 50%) from PLGA nanoparticles. PLGA nanoparticles encapsulating [225Ac]AcBLPhen significantly increased the delivery of [225Ac]Ac3+ to murine (E0771) and human (MCF-7 and MDA-MB-231) breast cancer cells with a concomitant increase in cell death over free [225Ac]Ac3+ in solution. These results demonstrate that PLGA nanoparticles have potential as radionuclide delivery platforms for TAT to advance precision radiotherapy for cancer. In addition, this technology offers an alternative use for ligands with poor aqueous solubility, low stability, or low affinity, allowing them to be repurposed for TAT by encapsulation within PLGA nanoparticles. [ABSTRACT FROM AUTHOR]

Objective(s): Obesity is a metabolic syndrome that leads to many chronic diseases worldwide. In this study, we investigate the antihyperlipidemic activities of chitosan nanoparticles (CH NPs) on silymarin (SIL) as a carrier in the drug delivery system that can improve some biochemical parameters and hormones in the model of hyperlipidemic rats receiving a high-fat diet (HFD). Materials and Methods: Physicochemical characterization of silymarin-loaded chitosannanoparticles (CH-SIL NPs) was done by Fourier-transform infrared (FTIR) spectroscopy, dynamic light scattering (DLS), and drug loading efficiency (LE). Diet-induced hyperlipidemic rats were treated with SIL (15 mg/kg/day) and CH-SIL NPs(15 mg/kg/day) for twelve weeks orally daily. The body weight loss (BW), food consumption, serum total cholesterol (TC), triglycerides (TG), high-density lipoprotein (HDL), levels of fasting blood glucose (FBG) in serum, serum insulin, cortisol, testosterone, and brain neuropeptide Y (NPY), Y1 and Y5 receptor mRNA expression were analyzed. Results: A significant reduction in BW and food consumption from 417 ± 16 g and 33 ± 1.03 in group HFD to 338 ± 10 g and 17.33 ± 1.02 in group CHS+HFD was observed, respectively. This data revealed that CH-SIL NPs improved hyperlipidemia, hyperinsulinemia, and hyperglycemia, reduced serum cortisol, and down-regulated NPY and Y1R with a significant increase in HDL and testosterone hormones compared to the control group. Conclusion: The developed Sil-loaded CH NPs were good agents for improving efficacy. It is the first report of the proposed weight loss mechanism of SIL CH NPs, thereby providing information about the anti-hyperlipidemic and antihyperglycemic effects of silymarin-loaded chitosan nanoparticles, a natural food with proper effects against metabolic disorders in case of hyperlipidemia that may lead to obesity and up-regulation of brain NPY. [ABSTRACT FROM AUTHOR]

Biodegradable nanomaterials can significantly improve the safety profile of nanomedicine. Germanium nanoparticles (Ge NPs) with a safe biodegradation pathway are developed as efficient photothermal converters for biomedical applications. Ge NPs synthesized by femtosecond‐laser ablation in liquids rapidly dissolve in physiological‐like environment through the oxidation mechanism. The biodegradation of Ge nanoparticles is preserved in tumor cells in vitro and in normal tissues in mice with a half‐life as short as 3.5 days. Biocompatibility of Ge NPs is confirmed in vivo by hematological, biochemical, and histological analyses. Strong optical absorption of Ge in the near‐infrared spectral range enables photothermal treatment of engrafted tumors in vivo, following intravenous injection of Ge NPs. The photothermal therapy results in a 3.9‐fold reduction of the EMT6/P adenocarcinoma tumor growth with significant prolongation of the mice survival. Excellent mass‐extinction of Ge NPs (7.9 L g−1 cm−1 at 808 nm) enables photoacoustic imaging of bones and tumors, following intravenous and intratumoral administrations of the nanomaterial. As such, strongly absorbing near‐infrared‐light biodegradable Ge nanomaterial holds promise for advanced theranostics. [ABSTRACT FROM AUTHOR]

Osteosarcoma (OS) is the most common primary malignant bone tumor. In the clinic, usual strategies for OS treatment include surgery, chemotherapy, and radiation. However, all of these therapies have complications that cannot be ignored. Therefore, the search for better OS treatments is urgent. Black phosphorus (BP), a rising star of 2D inorganic nanoparticles, has shown excellent results in OS therapy due to its outstanding photothermal, photodynamic, biodegradable and biocompatible properties. This review aims to present current advances in the use of BP nanoparticles in OS therapy, including the synthesis of BP nanoparticles, properties of BP nanoparticles, types of BP nanoparticles, and modification strategies for BP nanoparticles. In addition, we have discussed comprehensively the application of BP in OS therapy, including single, dual, and multimodal synergistic OS therapies, as well as studies about bone regeneration and antibacterial properties. Finally, we have summarized the conclusions, limitations and perspectives of BP nanoparticles for OS therapy [ABSTRACT FROM AUTHOR]

The properties of nanomedicines will influence how they can deliver drugs to patients reproducibly and effectively. For conventional pharmaceutical products, Chemistry, Manufacturing and Control (CMC) documents require monitoring stability and storage conditions. For nanomedicines, studying these important considerations is hindered by a lack of appropriate methods. In this paper, we show how combining radiolabelling with size exclusion chromatography, using a method called SERP (for Size Exclusion of Radioactive Polymers), can inform on the in vitro degradation of polymer nanoparticles. Using nanoparticles composed of biodegradable poly(lactic acid) (PLA) and poly(lactic- co -glycolic acid) (PLGA), we show that SERP is more sensitive than dynamic light scattering (DLS) and nanoparticle tracking analysis (NTA) to detect degradation. We also demonstrate that the properties of the polymer composition and the nature of the aqueous buffer affect nanoparticle degradation. Importantly, we show that minute changes in stability that cannot be detected by DLS and NTA impact the pharmacokinetic of nanoparticles injected in vivo. We believe that SERP might prove a valuable method to document and understand the pharmaceutical quality of polymer nanoparticles. [Display omitted] [ABSTRACT FROM AUTHOR]

The aim of this study was to evaluate the anti-osteoclastic activity of calcium hydroxide–loaded poly(lactic-co-glycolic acid) nanoparticles [Ca(OH) 2 -loaded PLGA NPs] in comparison to calcium hydroxide nanoparticles [Ca(OH) 2 NPs]. RAW 264.7 cell lines (third–fifth passage) were cultured and incubated with soluble receptor activator of nuclear factor kappa B ligand in triplicate. Subsequently, Ca(OH) 2 -loaded PLGA NPs and Ca(OH) 2 NPs were added for 7 days to evaluate their effects on receptor activator of nuclear factor kappa B ligand–induced osteoclast differentiation of RAW 264.7 cells by tartrate-resistant acid phosphatase activity. Additionally, a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was conducted to confirm the cytotoxicity of treatments to cells. Tartrate-resistant acid phosphatase staining showed a significant reduction in the osteoclast number when treated with Ca(OH) 2 -loaded PLGA NPs compared with Ca(OH) 2 NPs (P <.01). In comparison to the control, the number of osteoclasts significantly reduced upon treatment with Ca(OH) 2 -loaded PLGA NPs (P <.05), but there was no significant difference in Ca(OH) 2 NPs. Furthermore, osteoclast morphology in both treatment groups exhibited smaller sizes than the control group. Neither Ca(OH) 2 -loaded PLGA NPs nor Ca(OH) 2 NPs demonstrated cytotoxic effects on RAW264.7 cells. Both Ca(OH) 2 NPs with and without poly(lactic-co-glycolic acid) have the ability to inhibit osteoclast differentiation. However, Ca(OH) 2 -loaded PLGA NPs exhibit greater potential than Ca(OH) 2 NPs, making them a promising intracanal medicament for cases of root resorption. [ABSTRACT FROM AUTHOR]

Objectives: Wound healing and tissue regeneration have raised serious challenges for healthcare systems worldwide, affecting both aesthetic and health-related aspects of the community well-being. Wound healing is a complex sequence of physical, cellular, and molecular events involving cell recruitment, proliferation, as well as the synthesis and accumulation of the new extracellular matrix components. The present study aimed to histopathologically evaluate the application of zinc nanoparticles in conjunction with chitosan dressing for the wound healing of methicillin-resistant Staphylococcus aureus (MRSA) infected skin wounds in rats. Materials and Methods: In this experimental investigation, 28 healthy male rats were randomly divided into 4 groups, each of which including 7 rats. The wound healing process was evaluated based on histopathological studies and biochemical findings on days 7, 14, and 21. Results: According to the results from the two-way ANOVA analysis, the means of wound area in the study groups were statistically and significantly different on all evaluated days (P < 0.001). The highest wound area was associated with group III (i.e., wound with zinc oxide) on days 6, 18, 15, 12, and 9, while the lowest wound area was observed in group IV (i.e., wound with chitosannanoparticles-zinc oxide). A statistically significant difference was also found among the study groups in terms of the mean values of hydroxyproline (P < 0.001). According to the post hoc Tukey test for pairwise comparisons, a significant difference was observed among all groups regarding the hydroxyproline values (P < 0.001). Additionally, the highest collagen density was detected in the chitosan-nanoparticles-zinc oxide group. Conclusions: The application of biodegradable chitosan-nanoparticles-zinc oxide dressing significantly improved the histopathological and biochemical indices of the full-thickness skin wound healing. This study highlighted the effectiveness of chitosan-nanoparticleszinc oxide dressing in wound healing enhancement, indicating its potential application in wound healing. [ABSTRACT FROM AUTHOR]

Implantable biosensors have evolved to the cutting-edge technology of personalized health care and provide promise for future directions in precision medicine. This is the reason why these devices stand to revolutionize our approach to health and disease management and offer insights into our bodily functions in ways that have never been possible before. This review article tries to delve into the important developments, new materials, and multifarious applications of these biosensors, along with a frank discussion on the challenges that the devices will face in their clinical deployment. In addition, techniques that have been employed for the improvement of the sensitivity and specificity of the biosensors alike are focused on in this article, like new biomarkers and advanced computational and data communicational models. A significant challenge of miniaturized in situ implants is that they need to be removed after serving their purpose. Surgical expulsion provokes discomfort to patients, potentially leading to post-operative complications. Therefore, the biodegradability of implants is an alternative method for removal through natural biological processes. This includes biocompatible materials to develop sensors that remain in the body over longer periods with a much-reduced immune response and better device longevity. However, the biodegradability of implantable sensors is still in its infancy compared to conventional non-biodegradable ones. Sensor design, morphology, fabrication, power, electronics, and data transmission all play a pivotal role in developing medically approved implantable biodegradable biosensors. Advanced material science and nanotechnology extended the capacity of different research groups to implement novel courses of action to design implantable and biodegradable sensor components. But the actualization of such potential for the transformative nature of the health sector, in the first place, will have to surmount the challenges related to biofouling, managing power, guaranteeing data security, and meeting today's rules and regulations. Solving these problems will, therefore, not only enhance the performance and reliability of implantable biodegradable biosensors but also facilitate the translation of laboratory development into clinics, serving patients worldwide in their better disease management and personalized therapeutic interventions. [ABSTRACT FROM AUTHOR]

This study aimed to evaluate the antimicrobial activity of calcium hydroxide‐loaded poly(lactic‐co‐glycolic acid) nanoparticles (CH‐loaded PLGA NPs) on multi‐species biofilms. Human root blocks were prepared (n = 40), and multi‐species suspensions of Candida albicans, Enterococcus faecalis and Streptococcus gordonii were incubated within the root canals for 21 days. Canals (n = 10/group) were then medicated with saline solution (negative control), chlorhexidine (positive control), calcium hydroxide and CH‐loaded PLGA NPs for 7 days. Samples taken from the 0.1 mm root canal dentin were collected, and cell growth was detected by culture on BHI agar. The viable cell count of the Ca(OH)2, chlorhexidine gel and CH‐loaded PLGA NPs group was significantly lower than the normal saline group (p < 0.001). CH‐loaded PLGA NPs demonstrated a significant lower viable cell than Ca(OH)2 (p < 0.001); it has potential as a medicament for endodontic therapy. [ABSTRACT FROM AUTHOR]

This study presents a detailed investigation of the structural and surface modifications of Fe3O4 nanoparticles (NPs). Fourier Transform Infrared (FTIR) spectroscopy was utilized to analyze the distinct characteristic peaks of Fe3O4 NPs and their subsequent modifications with stearic acid (ST) layers. The FTIR analysis revealed characteristic peaks at 580 cm−1, and 441 cm−1, corresponding to the Fe‐O stretching vibrations of the bulk Fe3O4 NPs. The successful loading of stearic acid onto the Fe3O4 NPs was confirmed by the appearance of new peaks at 1413 cm−1 and 2908 cm−1, indicative of the asymmetric CH2 stretch and CH3 umbrella vibration modes of stearic acid. UV‐Vis spectroscopy further corroborated the efficient loading of tetracycline and ibuprofen onto Fe3O4/DST nanoparticles, as evidenced by changes in absorption spectra. N2 adsorption‐desorption isotherms illustrated the presence of micro and meso pores on the surface of Fe3O4 NPs, with alterations in pore volume and diameter post‐surface modification and drug loading. Evaluation of magnetic properties indicated a reduction in saturation magnetization after surface modification and drug loading, attributed to changes in homogeneity and surface moments. Differential Reflectance Spectroscopy (DRS) and Raman spectroscopy elucidated distinctive peaks and shifts in spectra, confirming the composition and structural changes in drug‐loaded nanofibers. [ABSTRACT FROM AUTHOR]

Growing environmental concerns and consumer demand for safe food lead to the innovation of biodegradable and active packaging materials. In this work, a biodegradable and active bilayer nanocomposite (TPS‐Y/NP) from two cassava starch‐based film layers is developed by casting, for possible use as packaging that can extend food shelf life. One layer is composed of a starch‐yerba mate extract film (TPS‐Y) and the other of a starch‐titanium dioxide nanoparticles nanocomposite (TPS‐NP). The use of the same starch matrix (TPS) in both films achieves a material with excellent interlayer compatibility. The bilayer presents activity against different pathogens and improvements in mechanical resistance and water vapor permeability (WVP) due to the contribution of the nanocomposite layer, and it shows antioxidant activity and greater deformation due to the layer with the natural extract. In addition, all films degrade in vegetable compost almost completely in two weeks. This bilayer film can be promisingly employed as a biodegradable and functional packaging to improve the useful life of food by conferring antioxidant and antibacterial activity. [ABSTRACT FROM AUTHOR]

A novel approach for the ultrasound-assisted synthesis of 3,4‑dihydropyrimidin‑2(1H)‑ones was developed by using biodegradable supported nanoparticles in a hydrotropic aqueous medium. Agar-supported NiO nanoparticles (NiO@AG NPs) were synthesized by in-situ co-precipitation method and characterization by means of spectroscopic and microscopic techniques indicates that spherical NiO NPs successfully supported on the surface of agar with particle size 31.22 nm containing Carbon, Nickel and Oxygen as major elements. NiO@AG NPs exhibit higher activity for the synthesis of 3,4‑dihydropyrimidin‑2(1H)‑ones in an aqueous medium by using hydrotropes with high (463.51 h−1) turn over frequency. Short reaction time, high efficiency, centrifugation-free method of separation of the catalyst, and column chromatography-free isolation of the product are the key factor of this protocol. The easy synthetic method and stable form of NiO nanoparticles supported on agar suggest that it could be an efficient material for water-based organic transformation on a large scale with high turnover frequency in the future. [ABSTRACT FROM AUTHOR]

Precise targeting is a major prerequisite for effective cancer therapy because it ensures a sufficient therapeutic dosage in tumors while minimizing off-target side effects. Herein, we report a live-macrophage-based therapeutic system for high-efficiency tumor therapy. As a proof of concept, anti-human epidermal growth factor receptor-2 (HER2) affibodies were genetically engineered onto the extracellular membrane of macrophages (AE-Mφ), which further internalized doxorubicin (DOX)-loaded poly(lactic- co -glycolic acid) nanoparticles (NPs) to produce a macrophage-based therapeutic system armed with anti-HER2 affibodies. NPs(DOX)@AE-Mφ were able to target HER2+ cancer cells and specifically elicit affibody-mediated cell therapy. Most importantly, the superior HER2 + -targeting capability of NPs(DOX)@AE-Mφ greatly guaranteed high accumulation at the tumor site for improved chemotherapy, which acted synergistically with cell therapy to significantly enhance anti-tumor efficacy. This study suggests that NPs(DOX)@AE-Mφ could be utilized as an innovative 'living targeted drug' platform for combining both macrophage-mediated cell therapy and targeted chemotherapy for the individualized treatment of solid tumors. Ning et al. present a live-macrophage-based therapeutic system as a novel dosage form for high-efficiency tumor therapy. Anti-human epidermal growth factor receptor-2 (HER2) affibodies were genetically engineered on the extracellular membrane of macrophages (AE-Mφ), which further internalized doxorubicin (DOX)-loaded poly (lactic- co -glycolic acid) nanoparticles (NPs) to produce as an innovative "living targeted drug" platform of delivery science and technology for combining both macrophage-mediated cell therapy and targeted chemotherapy for individualized treatment of solid tumors. [Display omitted] [ABSTRACT FROM AUTHOR]

Biodegradable gelatin coating embedded with different concentrations (1, 3 and 5%) of silver nanoparticles (AgNPs) designed as an antimicrobial packaging system to improve the quality of toast bread samples and prolong their shelf life when stored at room temperature for a 5-day period. The findings revealed a significant enhancement in the physical (film thickness, solubility, water vapor permeability, oxygen permeability) and mechanical (tensile strength and elongation at break) properties of the gelatin-based films upon the integration of AgNPs up to 3% (P < 0.05). SEM analysis displayed a homogeneous structure in the nanocomposite films when AgNPs were integrated at concentrations ≤ 3%. This was complemented by the confirmation of the interaction between the polymer and nanoparticles, as well as the crystallinity of AgNPs in the film, validated through FT-IR spectroscopy and XRD respectively. The evaluation of physicochemical and microbial characteristics of the coated bread revealed that samples containing 3% of AgNPs effectively preserved moisture content and water activity, minimized bread firmness and staleness, thereby maintaining the lightness index (L*) of the crust/crumb in comparison to the control (gelatin alone). Furthermore, all actively coated treatments, particularly those with AgNPs at concentrations ≥ 3%, demonstrated robust antimicrobial activity by preventing bacterial and mold growth during 5 days. [ABSTRACT FROM AUTHOR]

Cell membrane-coated nanoparticles (CNPs) are a promising tool for addressing biomedical challenges. CNPs use natural cell membranes to cloak synthetic nanoparticle cores, creating a biomimetic platform with enhanced biocompatibility and immune evasion properties. Different cell types can be used to create CNPs with unique properties for specific applications, such as drug delivery. Researchers have developed a modular approach to functionalize CNPs by genetically modifying the cell membrane component to express an adapter protein. This allows for the rapid attachment of different functional ligands to the CNPs. The modular CNPs demonstrated affinity to cells with high surface expression of specific markers and showed promising results in delivering chemotherapeutic drugs in a tumor model. The modular approach reduces development time and allows for the screening of a large number of ligands. However, further research is needed to address considerations such as batch-to-batch variability, synthesis uniformity, ligand production, and functionalization confirmation. The goal is to generate large libraries of CNPs and ligands to manage a diverse range of diseases. [Extracted from the article]

Background: Cancer is a significant global health issue, resulting from uncontrolled cell division leading to abnormal cell or tissue growth. Traditional chemotherapeutic techniques have investigated a wide variety of pharmaceutically active molecules despite their poor bioavailability, quick renal clearance, inconsistent distribution, and unavoidable side effects. Green synthesis, unlike chemical methods, prioritizes eco-friendliness and cost-effectiveness. Using natural sources like plant extracts, it minimizes environmental impact, reduces costs, and aligns with sustainability goals. Operating under milder conditions, it consumes less energy compared to traditional approaches. Green synthesis is a highly promising and efficient method for producing nanoparticles due to its versatility and scalability. Main body: Nanotechnology is making progress in cancer treatment because of nanoparticles' tiny size, large surface area, adaptability, and functionality, as well as their potential to induce apoptotic pathways and fast penetration or internalization into cancer cells. Biosynthesis of metallic nanoparticles using plant or microbe extracts is attracting attention to replace toxic chemicals with phytochemicals that can act as reducing, capping, or stabilizing agents and improve metallic nanoparticles biocompatibility, antitumor, and antioxidant properties. This review focuses on biosynthesized metallic nanoparticles and their anticancer effects on breast, prostate, skin, cervical, colorectal, lung, and liver cancer. Conclusion: Biosynthesis of nanoparticles for cancer therapy stands at the forefront of innovative and sustainable approaches. Despite challenges, ongoing research demonstrates the potential of biosynthesis to revolutionize cancer nanomedicine, emphasizing the need for continued exploration and collaboration in this rapidly advancing field. Overall, this review offers a comprehensive understanding of the most recent developments in biosynthesized metallic nanoparticles for the treatment of cancer as well as their potential future applications in medicine. [ABSTRACT FROM AUTHOR]

Biodegradable polymer nanocomposites (BPNCs) are advanced materials that have gained significant attention over the past 20 years due to their advantages over conventional polymers. BPNCs are eco-friendly, cost-effective, contamination-resistant, and tailorable for specific applications. Nevertheless, their usage is limited due to their unsatisfactory physical and mechanical properties. To improve these properties, nanofillers are incorporated into natural polymer matrices, to enhance mechanical durability, biodegradability, electrical conductivity, dielectric, and thermal properties. Despite the significant advances in the development of BPNCs over the last decades, our understanding of their dielectric, thermal, and electrical conductivity is still far from complete. This review paper aims to provide comprehensive insights into the fundamental principles behind these properties, the main synthesis, and characterization methods, and their functionality and performance. Moreover, the role of nanofillers in strength, permeability, thermal stability, biodegradability, heat transport, and electrical conductivity is discussed. Additionally, the paper explores the applications, challenges, and opportunities of BPNCs for electronic devices, thermal management, and food packaging. Finally, this paper highlights the benefits of BPNCs as biodegradable and biodecomposable functional materials to replace traditional plastics. Finally, the contemporary industrial advances based on an overview of the main stakeholders and recently commercialized products are addressed. [ABSTRACT FROM AUTHOR]

This study investigates the suitability of using caffeine-treated and untreated black cherry (Prunus serotina Ehrh.) wood as a polylactide filler. Composites containing 10%, 20%, and 30% filler were investigated in terms of increasing the nucleating ability of polylactide, as well as enhancing its resistance to microorganisms. Differential scanning calorimetry studies showed that the addition of caffeine-treated wood significantly altered the crystallization behavior of the polymer matrix, increasing its crystallization temperature and degree of crystallinity. Polarized light microscopic observations revealed that only the caffeine-treated wood induced the formation of transcrystalline structures in the polylactide. Incorporation of the modified filler into the matrix was also responsible for changes in the thermal stability and decreased hydrophilicity of the material. Most importantly, the use of black cherry wood treated with caffeine imparted antifungal properties to the polylactide-based composite, effectively reducing growth of Fusarium oxysporum, Fusarium culmorum, Alternaria alternata, and Trichoderma viride. For the first time, it was reported that treatment of wood with a caffeine compound of natural origin alters the supermolecular structure, nucleating abilities, and imparts antifungal properties of polylactide/wood composites, providing promising insights into the structure-properties relationship of such composites. [ABSTRACT FROM AUTHOR]

Poly(butylene adipate–co–terephthalate) (PBAT) is widely used for production of biodegradable films due to its high elongation, excellent flexibility, and good processability properties. An effective way to develop more accessible PBAT-based bioplastics for wide application in packaging is blending of PBAT with thermoplastic starch (TPS) since PBAT is costly with prices approximately double or even triple the prices of traditional plastics like polyethylene. This study is focused on investigating the influence of TPS/PBAT blend ratio and montmorillonite (MMT) content on the physical and mechanical properties and molecular mobility of TPS–MMT/PBAT nanocomposites. Obtained TPS–MMT/PBAT nanocomposites through the melt blending process were characterized using tensile testing, dynamic mechanical thermal analysis (DMTA), and X-ray diffraction (XRD), as well as solid-state 1H and 13C NMR spectroscopy. Mechanical properties demonstrated that the addition of TPS to PBAT leads to a substantial decrease in the tensile strength as well as in the elongation at break, while Young's modulus is rising substantially, while the effect of the MMT addition is almost negligible on the tensile stress of the blends. DMTA results confirmed the formation of TPS domains in the PBAT matrix. With increasing TPS content, mobility of starch-rich regions of TPS domains slightly increases. However, molecular mobility in glycerol-rich regions of TPS domains in the blends was slightly restricted. Moreover, the data obtained from 13C CP/MAS NMR spectra indicated that the presence of TPS in the sample decreases the mobility of the PBAT chains, mainly those located at the TPS/PBAT interfaces. [ABSTRACT FROM AUTHOR]

Background: Pyrazinamide is a Biopharmaceutical Classification System class III antibiotic indicated for active tuberculosis. Methods: In the present work, pyrazinamide-loaded biodegradable polymeric nanoparticles (PNPs) based dry powder inhaler were developed using the double emulsion solvent evaporation technique and optimized using design of experiments to provide direct pulmonary administration with minimal side effects. Batches were characterized for various physicochemical and aerosol performance properties. Results: Optimized batch exhibited particle size of 284.5 nm, % entrapment efficiency of 71.82%, polydispersibility index of 0.487, zeta potential of −17.23 mV, and in vitro drug release at 4 hours of 79.01%. Spray-dried PNPs were evaluated for drug content, in vitro drug release, and kinetics. The particle mass median aerodynamic diameter was within the alveolar region's range (2.910 μm). In the trachea and lung, there was a 2.5- and 1.2-fold increase in in vivo deposition with respect to pure drug deposition, respectively. In vitro drug uptake findings showed that alveolar macrophages with pyrazinamide PNPs had a considerably higher drug concentration. Furthermore, accelerated stability studies were carried out for the optimized batch. Results indicated no significant change in the evaluation parameters, which showed stability of the formulation for at least a 6-month period. Conclusion: PNPs prepared using biodegradable polymers exhibited efficient pulmonary drug delivery with decent stability. [ABSTRACT FROM AUTHOR]

MicroRNAs (miRNAs) have a crucial role in the regulation of gene expression in tumor development, invasion, and metastasis. Herein, miRNA-340 (miR-340) has been shown to play tumor suppressor activity in breast cancer (BC). However, the clinical applications of miRNAs request the development of safe and effective delivery systems capable of protecting nucleic acids from degradation. In this study, biodegradable chitosan nanoparticles incorporating miR-340 plasmid DNA (pDNA) (miR-340 CNPs) were synthesized and characterized. Then, the anti-tumor effects of miR-340 CNPs were investigated using 4T1 BCE cells. The spherical nanoparticles (NPs) with an appropriate mean diameter of around 266 ± 9.3 nm and zeta potential of +17 ± 1.8 mV were successfully prepared. The NPs showed good stability, high entrapment efficiency and a reasonable release behavior, meanwhile their high resistance against enzymatic degradation was verified. Furthermore, NPs demonstrated appropriate transfection efficiency and could induce apoptosis, so had toxicity in 4T1 BCE cells. Also, CD47 expression on the surface of cancer cells was significantly reduced after treatment with miR-340 CNPs. The results showed that miR-340 CNPs augmented the expression of P-27 in BC cells. Furthermore, miR-340 CNPs caused down-regulation of BRP-39 (breast regression protein-39) increasingly suggested as a prognostic biomarker for neoplastic diseases like BC. In conclusion, our data show that miR-340 CNPs can be considered as a promising new platform for BC gene therapy. [ABSTRACT FROM AUTHOR]

Long-acting injectable cabotegravir is more effective than daily oral PrEP at preventing HIV transmission due to improved adherence, but requires bi-monthly large-volume intramuscular injections. Subcutaneous (SC) contraceptive implants can be formulated with antiretrovirals for extended-duration HIV PrEP. Islatravir (ISL) is a first-in-class, investigational antiretroviral with pharmacologic properties well-suited for implant delivery. We performed preclinical studies for the development of a reservoir-style, poly(ε-caprolactone) ISL-eluting implant by conducting a single-dose SC ISL dose-ranging pharmacokinetic (PK) study of 0.1, 0.3, and 1 mg/kg in adult Wistar rats. Non-compartmental analysis was conducted, and dose proportionality assessed for ISL plasma and intracellular islatravir-triphosphate (ISL-tp). Population PK models estimated ISL's unit impulse response to deconvolve ISL-implant in vivo absorption rate (mg/day) and cumulative mass (mg) from published rat plasma PK (n = 10). Drug release was interpreted using four kinetic models. Dose proportionality was affirmed for ISL and ISL-tp. A first-order, two-compartment model fitted the SC ISL bolus data. Mean (SD) absorption rate from 0 to 154 days was 0.072 ± 0.024 mg/day, and cumulative mass at 154 days was 8.67 ± 3.22 mg. ISL absorption was well-described by zero-order (r2 = 0.95) and Ritger–Peppas (r2 = 0.98). Our zero-order ISL-release poly(ε-caprolactone) implant is projected to achieve clinical PK above ISL-tp's PrEP efficacy threshold. Continued development for HIV PrEP applications is warranted. [ABSTRACT FROM AUTHOR]

Alzheimer's disease (AD) is a complex neurodegenerative disorder with a significant global impact on public health. The emergence of atypical clinical phenotypes challenges traditional diagnostic approaches, necessitating a deeper exploration of biomarkers for accurate identification. The US Food and Drug Administration (FDA) classification of biomarkers and their integration into different stages of AD provide a structured framework for their application in research and clinical settings. Within the context of AD drug development, biomarkers are essential for participant selection, target engagement evaluation, and assessment of pathological hallmarks, including Aβ and tau protein abnormalities. The incorporation of nanoparticles with a biodegradable approach introduces innovative strategies to address the complexities of AD. This paper extensively discusses biomarkers associated with synaptic dysfunction, neuroinflammation, and glial activation, recognizing their significance in elucidating disease mechanisms. Common pathologies such as synuclein and TDP‐43 further underscore the multifaceted nature of AD. Current biomarkers for AD diagnosis, encompassing cerebral spinal fluid (CSF) biomarkers and various imaging modalities, reflect the ongoing efforts to enhance early detection and monitoring. Intriguingly, novel biomarkers continue to emerge, offering promising avenues for improved understanding and intervention. Current review provides a comprehensive survey of biomarkers for AD, elucidating their diverse roles across different aspects of the disease. By highlighting their contributions to diagnosis, drug development, and mechanistic insights, this overview underscores the importance of biomarker research in the pursuit of effective AD management and treatment strategies. [ABSTRACT FROM AUTHOR]

The aim of the present study was to fabricate, characterize, and evaluate the in vitro antimicrobial and antioxidant properties of zein/polyvinyl alcohol (ZN/PVA) nanofibers containing 2% and 4% of thymoquinone (TQ), either alone or in combination with electrosprayed ZN nanoparticles containing 1% and 2% of resveratrol (RS). According to scanning electron microscopy analysis, the diameter of nanofibers and nanoparticles increased with increasing TQ and RS concentrations, respectively. The molecular interaction between ZN or PVA polymers and TQ or RS was confirmed by Fourier transform infrared spectroscopy. Thermogravimetric analysis showed that the thermal stability of nanofibers did not change with the addition of TQ and RS. Moreover, incorporation of TQ in nanofibers along with RS nanoparticles increased their antibacterial and free radical scavenging activities based on broth dilution and DPPH methods, respectively (p ≤.05). Escherichia coli O157:H7 (as a Gram‐negative pathogenic bacteria) was more resistant to all treatments than Staphylococcus aureus (as a Gram‐positive pathogenic bacteria). In addition, the combined use of TQ in nanofibers and RS nanoparticles had antagonistic antibacterial and synergistic antioxidant effects. The best results were obtained with ZN/PVA nanofiber containing 4% TQ and electrosprayed with 2% RS nanoparticles (p ≤.05). According to the results of the present study, biodegradable ZN/PVA nanofiber containing TQ and electrosprayed with RS nanoparticles can be used as a novel active packaging material in the food industry. [ABSTRACT FROM AUTHOR]

Induction of antigen-specific immune tolerance for the treatment of allergic or autoimmune diseases is an attractive strategy. Herein, we investigated the protective effect of a transdermal microneedle patch against allergic asthma by stimulating allergen-specific immune tolerance. We fabricated biodegradable tolerogenic nanoparticles (tNPs) that are loaded with a model allergen ovalbumin (OVA) and an immunomodulator rapamycin, and filled the tNPs into microneedle tips by centrifugation to form sustained-release microneedles. After intradermal immunization, the microneedles successfully delivered the cargos into the skin and sustainedly released them for over 96 h. Importantly, the microneedles induced allergen-specific regulatory T cells (Treg), decreased the levels of pro-inflammatory cytokines and antibodies while increased anti-inflammation cytokines, finally leading to restored immune homeostasis. The lung tissue analysis illustrated that the sustained-release microneedles significantly reduced the infiltration of eosinophils, decreased the accumulation of mucus and collagen, and significantly relived asthma symptoms. Our results suggested that the sustained-release microneedle-based transdermal delivery system can induce antigen-specific immune tolerance with improved compliance and efficacy, providing a new therapeutic strategy for the treatment of allergic and autoimmune diseases. Sustained-release microneedles induced allergen-specific immune tolerance to protect against allergic asthma. The sustained-release microneedles successfully co-delivered allergens and immunomodulators into the skin, down-regulated co-stimulatory molecules of DCs and induced allergen-specific Tregs, restored the immune response, and finally reduced inflammatory cell infiltration in the lung, inhibited airway mucus accumulation and prevented allergic asthma progression. [Display omitted] • Tolerogenic nanoparticle-loaded microneedles induce effective immune tolerance against asthma. • The incorporation of tolerogenic nanoparticles can improve the immune-tolerance induction efficiency of microneedles. • Microneedle-mediated intradermal vaccination of auto-antigen increases the recruitment of antigen-presenting cells. • Co-administration of auto-antigen and immune-modulator is crucial for immune tolerance induction. [ABSTRACT FROM AUTHOR]

Hepatic tissue engineering has been applied for the treatment of intractable liver diseases, and hepatocyte sheets are promising for this purpose. However, hepatocyte sheets have poor survival after transplantation because of their high metabolic activity. In this study, we aimed to develop basic fibroblast growth factor (bFGF)-releasing nanoparticles to prolong the survival of hepatocyte sheets after transplantation. The nanoparticles were prepared by electrospraying a bFGF-dispersed poly(D, l -lactide- co -glycolide) emulsion. bFGF-loaded PLGA nanoparticles can be developed by optimizing the applied electrospray voltage and the oil:water ratio of the emulsion. The prepared nanoparticles exhibited prompt release at the initial duration and continuous gradual release at the subsequent duration. Hepatocyte sheet engraftment was evaluated by transplanting hepatocyte sheets containing the prepared nanoparticles into rats. The hepatocyte sheets with the prepared nanoparticles exhibited longer survival than those without the bFGF nanoparticles or solution owing to the local and continuous release of bFGF from the nanoparticles and the subsequent enhanced angiogenesis at the transplantation site. These results indicated that the prepared bFGF-releasing nanoparticles can enhance the efficiency of hepatocyte sheet transplantation. The developed bFGF-releasing nanoparticles would be useful for the transplantation of cellular tissue with post-transplantation survival challenges. [Display omitted] [ABSTRACT FROM AUTHOR]

Background: Multiple drug-delivery systems obtained by loading nanoparticles (NPs) with different drugs that have different physicochemical properties present a promising strategy to achieve synergistic effects between drugs or overcome undesired effects. This study aims to develop a new NP by loading quercetin (Que) and valproic acid (VPA) into chitosan. In this context, our study investigated the antioxidant activities of chitosan NPs loaded with single and dual drugs containing Que against oxidative stress. Method: The synthesis of chitosan NPs loaded with a single (Que or VPA) and dual drug (Que and VPA), the characterization of the NPs, the conducting of in vitro antioxidant activity studies, and the analysis of the cytotoxicity and antioxidant activity of the NPs in human neuroblastoma SH-SY5Y cell lines were performed. Result: The NP applications that protected cell viability to the greatest extent against H2O2-induced cell damage were, in order, 96 µg/mL of Que-loaded chitosan NP (77.30%, 48 h), 2 µg/mL of VPA-loaded chitosan NP (70.06%, 24 h), 96 µg/mL of blank chitosan NP (68.31%, 48 h), and 2 µg/mL of Que- and VPA-loaded chitosan NP (66.03%, 24 h). Conclusion: Our study establishes a successful paradigm for developing drug-loaded NPs with a uniform and homogeneous distribution of drugs into NPs. Chitosan NPs loaded with both single and dual drugs possessing antioxidant activity were successfully developed. The capability of chitosan NPs developed at the nanometer scale to sustain cell viability in SH-SY5Y cell lines implies the potential of intranasal administration of chitosan NPs for future studies, offering protective effects in central nervous system diseases. [ABSTRACT FROM AUTHOR]

The structural diversity and tunability of the capsid proteins (CPs) of various icosahedral and rod-shaped viruses have been well studied and exploited in the development of smart hybrid nanoparticles. However, the potential of CPs of the wide-spread flexuous filamentous plant viruses remains to be explored. Here, we show that we can control the shape, size, RNA encapsidation ability, symmetry, stability and surface functionalization of nanoparticles through structure-based design of CP from potato virus Y (PVY). We provide high-resolution insight into CP-based self-assemblies, ranging from large polymorphic or monomorphic filaments to smaller annular, cubic or spherical particles. Furthermore, we show that we can prevent CP self-assembly in bacteria by fusion with a cleavable protein, enabling controlled nanoparticle formation in vitro. Understanding the remarkable structural diversity of PVY CP not only provides possibilities for the production of biodegradable nanoparticles, but may also advance future studies of CP's polymorphism in a biological context. Capsid proteins (CPs) of various icosahedral and rod-shaped viruses exhibit structural diversity and tunability as well as application in smart hybrid nanoparticles, however, the potential of CPs of filamentous plant viruses remains underexplored. Here, the authors exploit the structure-based design of CP from potato virus Y to tune the shape, size, RNA encapsidation ability, symmetry, stability, and surface functionalization of nanoparticles. [ABSTRACT FROM AUTHOR]

The biological effects of ionizing radiation are exploited in the clinical practice of radiotherapy to destroy tumour cells while sparing the surrounding normal tissue. While most of the radiotherapy research focused on DNA damage and repair, recently a great attention is going to cells' interactions with the mechanical microenvironment of both malignant and healthy tissues after exposure. In fact, the stiffness of the extracellular matrix can modify cells' motility and spreading through the modulation of transmembrane proteins and surface receptors' expression, such as CD-44. CD-44 receptor has held much interest also in targeted-therapy due to its affinity with hyaluronic acid, which can be used to functionalize biodegradable nanoparticles loaded with chemotherapy drugs for targeted therapy. We evaluated changes in CD-44 expression in two mammary carcinoma cell lines (MCF10A and MDA-MB-231) after exposure to X-ray (2 or 10 Gy). To explore the role of the mechanical microenvironment, we mimicked tissues' stiffness with polyacrylamide's substrates producing two different elastic modulus values (0.5 and 15 kPa). We measured a dose dependent increase in CD-44 relative expression in tumour cells cultured in a stiffer microenvironment. These findings highlight a crucial connection between the mechanical properties of the cell's surroundings and the post-radiotherapy expression of surface receptors. [ABSTRACT FROM AUTHOR]

Background: Fungal infections are the primary cause of skin diseases. Topical application of antifungal drugs is the most preferred treatment which is associated with key limitations viz. need for high doses and frequency of application. By considering the limitations of current topical treatment, the present study involves the formulation and characterization of luliconazole nanogel. Materials and Methods: The luliconazole nanoparticles were prepared by using biodegradable polymer PLGA 50:50 and dispersed in polymeric dispersion prepared by Carbopol 940 and HPMC K4M. For optimization of nanoparticles as well as their polymeric dispersion a factor-three level (32) design was implemented. Optimized nanoparticles were characterized for various parameters viz. particle size, PDI, entrapment efficiency, XRD, SEM, whereas the nanogel was investigated for viscosity, cumulative drug release, spreadability, extrudability, skin irritation test, and antifungal activity. Results: The nine batches of nanoparticles as well as nanogel were prepared. Nanoparticles prepared by using 100 mg PLGA at 6 HPH cycles showed size, PDI, and % entrapment as 406 nm and 87% respectively was the desired batch. The XRD and SEM study ensured the encapsulation of drug with satisfactory surface morphology. Nano-gel formulated with 0.3% Carbopol and 1.0% HPMC was selected as optimized; it showed viscosity and % cumulative drug release as 3650 cP and 54% respectively. Nanogel showed significant sustained luliconazole release (54.12%) in comparison to simple nanoparticles (65.22%). The formulation showed improved antifungal activity than standard treatment without any skin irritation signs. Conclusion: Prepared nano-gel is a promising alternative to the current treatment. [ABSTRACT FROM AUTHOR]

Objective and Aim: Numerous clinical trials indicated combination regimens containing gemcitabine could extend progression-free survival of breast cancer patients without increasing the incidence of serious adverse effects. Orally administered gemcitabine is being metabolized by enzymes present in intestinal cells rapidly; thereupon, the current study was aimed to preparing, optimizing, and evaluating cytotoxicity of wheat germ agglutinin conjugated gemcitabine-chitosan nanoparticles (WGA-Gem-CNPs) in MCF-7 and HEK293 cells and to determining their cellular uptake by Caco-2 cells. Methods: Gem-CNPs were prepared by Ionic Gelation method and optimum formulation was implied for WGA conjugation optimisation. Nanoparticles formation was approved by FTIR and DSC analyses; then particles were characterized by DLS and release profile was prepared. MTT assay was performed in MCF-7 and HEK293. Results: Optimized Gem-CNPs and WGA-Gem-CNPs particle size were estimated as 126.6 ± 21.8 and 144.8 ± 36.1 nm, respectively. WGA conjugation efficacy was calculated as 50.98 ± 2.32 percent and encapsulation efficiency in WGA-Gem-CNPs was 69.44 ± 3.41 percent. Three-hour Caco-2 cellular uptake from Gem-CNPs and WGA-Gem-CNPs were estimated as averagely 3.5 and 4.5 folds higher than free drug, respectively. Gem-CNPs and WGA-Gem-CNPs reduced IC50 in MCF-7 cells by 2 and 2.5 folds, respectively; such decrease for HEK293 cells was as much as 2.4 and 6.3 folds, in same order. Conclusion: Demonstrated significant in vitro uptake of WGA-Gem-CNPs and cytotoxicity might be considered for more studies as a potential carrier for oral delivery of gemcitabine. [ABSTRACT FROM AUTHOR]

Neuropathic pain is a critical source of comorbidity following spinal cord injury (SCI) that can be exacerbated by immune-mediated pathologies in the central and peripheral nervous systems. In this article, we investigate whether drug-free, biodegradable, poly(lactide-co-glycolide) (PLG) nanoparticle treatment mitigates the development of post-SCI neuropathic pain in female mice. Our results show that acute treatment with PLG nanoparticles following thoracic SCI significantly reduces tactile and cold hypersensitivity scores in a durable fashion. Nanoparticles primarily reduce peripheral immune-mediated mechanisms of neuropathic pain, including neuropathic pain-associated gene transcript frequency, transient receptor potential ankyrin 1 nociceptor expression, and MCP-1 (CCL2) chemokine production in the subacute period after injury. Altered central neuropathic pain mechanisms during this period are limited to reduced innate immune cell cytokine expression. However, in the chronic phase of SCI, nanoparticle treatment induces changes in both central and peripheral neuropathic pain signaling, driving reductions in cytokine production and other immune-relevant markers. This research suggests that drug-free PLG nanoparticles reprogram peripheral proalgesic pathways subacutely after SCI to reduce neuropathic pain outcomes and improve chronic central pain signaling. [ABSTRACT FROM AUTHOR]